NYSE:OI
NYSE:OIPackaging

O-I Glass (OI): Evaluating Valuation After Profit Turnaround and Upgraded Earnings Guidance

O-I Glass (NYSE:OI) delivered a sharp turnaround in its third quarter 2025 results, moving from a net loss to net profit and raising its full-year adjusted earnings guidance. This shift highlights real progress in its ongoing restructuring. See our latest analysis for O-I Glass. After a tough start to the year, O-I Glass’s fortunes reversed sharply. Momentum soared with a 14% share price return over the past week and a solid 10.8% over the last month. Despite recent volatility, the stock’s...
NYSE:GHC
NYSE:GHCConsumer Services

Graham Holdings (GHC): Assessing Valuation Following Strong Q3 Earnings and Segment Growth

Graham Holdings (GHC) just posted third quarter earnings that caught attention, thanks to double-digit increases in both revenue and net income compared to last year. Key growth drivers included the healthcare, Kaplan, and manufacturing segments. See our latest analysis for Graham Holdings. Graham Holdings’ solid third quarter capped off a year of steady momentum. The share price climbed over 21% year-to-date and the company notched a 10% total shareholder return over the past twelve months...
NasdaqGS:SPSC
NasdaqGS:SPSCSoftware

$100 Million Share Buyback and New CCO Could Be a Game Changer for SPS Commerce (SPSC)

SPS Commerce, Inc. reported strong third-quarter results with US$189.9 million in sales and net income of US$25.57 million, confirmed upbeat guidance for 2025, and announced a new US$100 million share repurchase program, with board authorization and progress updates provided in recent days. In addition to ongoing financial momentum, the appointment of a new Chief Commercial Officer with global experience may influence the company’s approach to growth and customer engagement going...
NYSE:XYL
NYSE:XYLMachinery

Xylem (XYL): Valuation Insights Following Raised Outlook and Strong Q3 Performance

Xylem (XYL) grabbed attention after posting third-quarter results that exceeded expectations, with revenue growth reported across several divisions. The company also raised its full-year outlook, highlighting management’s optimism heading into year-end. See our latest analysis for Xylem. Xylem’s strong quarterly update and raised full-year outlook seem to have energized investor sentiment, with the stock’s latest share price at $151.31 and a year-to-date share price return of 30.5%. In the...
NYSE:ALX
NYSE:ALXRetail REITs

Assessing Alexander’s (ALX) Valuation Following Upgraded Earnings Outlook and Strong 2024 Performance

Alexander's (ALX) has caught investor attention following a renewed bump in its consensus earnings outlook. This shift comes as the company outpaces sector and industry peers despite recent dips in year-over-year quarterly results. See our latest analysis for Alexander's. This positive run comes after a steady dividend announcement and earnings results that, while down from last year, have not reduced investor optimism. Alexander’s share price has climbed 18.1% year-to-date and its total...
NasdaqGS:KHC
NasdaqGS:KHCFood

A Look at Kraft Heinz’s (KHC) Valuation Following Spin-Off Plans and Reduced 2025 Outlook

Kraft Heinz (KHC) announced plans for a tax-free spin-off, splitting the company into two independent public firms. This major restructuring follows recent mixed third-quarter results and softer sales volumes. See our latest analysis for Kraft Heinz. Recent months have been eventful for Kraft Heinz, from launching bold new product collaborations to unveiling a major spin-off plan. Despite these headline-grabbing moves, the share price has been trending lower, posting a year-to-date share...
NasdaqGM:TNDM
NasdaqGM:TNDMMedical Equipment

Tandem Diabetes Care (TNDM): Assessing Valuation After a 21.98% Single-Day Stock Rally

Tandem Diabetes Care (TNDM) has caught the eye of investors lately, with its shares climbing 22% over the past month. As the company continues its journey in diabetes technology, recent stock movement sparks questions about what could be driving this renewed interest. See our latest analysis for Tandem Diabetes Care. While Tandem Diabetes Care's share price has surged 21.98% in a single day, momentum comes after a challenging year, with a total shareholder return over the past twelve months...
NYSE:DTE
NYSE:DTEIntegrated Utilities

Data Center Contract Controversy Could Be a Game Changer for DTE Energy (DTE)

In recent days, DTE Energy's request for expedited regulatory approval to power a multi-billion-dollar data center campus in Michigan has sparked significant scrutiny, with the Michigan Attorney General and state lawmakers calling for public hearings to ensure customer protections and transparency in the process. This controversy underscores heightened regulatory attention and community interest regarding the balance between large-scale infrastructure commitments and ratepayer risk as DTE...
NasdaqGS:PCAR
NasdaqGS:PCARMachinery

Assessing PACCAR (PCAR) Valuation Following Recent Share Price Momentum

PACCAR (PCAR) shares edged slightly higher in recent trading, extending nearly 6% gains for the month. Investors may be looking for clues in the company’s steady revenue and net income growth, especially with the stock’s long-term track record. See our latest analysis for PACCAR. PACCAR’s recent 6% share price return over the last month signals renewed investor interest, even as its year-to-date performance lags. While short-term moves remain mixed, a resilient long-term total shareholder...
NasdaqGM:VERX
NasdaqGM:VERXSoftware

A Fresh Look at Vertex (VERX) Valuation After Q3 Earnings, Guidance Cut, and $150M Buyback

Vertex (VERX) grabbed investors’ attention this week after reporting third quarter earnings that revealed both solid progress and fresh hurdles. Cloud revenue jumped, but customer bankruptcies and faster migrations prompted management to lower Q4 guidance. See our latest analysis for Vertex. After a sharp drop in the past month, which includes a 21.3% one-month share price decline and a year-to-date slide of over 63%, Vertex is searching for stability as investors digest cautious guidance,...
NasdaqGS:CRNX
NasdaqGS:CRNXPharmaceuticals

Assessing Crinetics Pharmaceuticals (CRNX) Valuation After Recent Share Price Slide and Revenue Growth

Crinetics Pharmaceuticals (CRNX) shares have seen mixed movement over the past month, even as the company continues to report strong annual revenue growth. Investors are watching for updates that could influence the stock’s path forward. See our latest analysis for Crinetics Pharmaceuticals. After a tough start to the year, Crinetics Pharmaceuticals’ share price has lost some ground recently, slipping another 11% over the past month. Still, the stock’s longer-term momentum is impressive...
NasdaqGS:STNE
NasdaqGS:STNEDiversified Financial

StoneCo (NasdaqGS:STNE): Evaluating Valuation Prospects Following Recent Volatility

StoneCo (NasdaqGS:STNE) has been on investors’ radars lately, as shares moved in response to recent trading trends and broader market sentiment. Its stock activity reflects evolving views on the company’s future within the diversified financials sector. See our latest analysis for StoneCo. StoneCo’s share price has delivered a rollercoaster ride this year, marked by a tremendous year-to-date gain of 107.78% that grabbed investor attention. After a strong performance rallying into the second...
NYSE:SLVM
NYSE:SLVMForestry

Assessing Sylvamo (SLVM) Valuation: Is Recent Momentum Signaling a Turnaround Opportunity?

Sylvamo (SLVM) has seen its stock performance shift recently, catching the attention of investors assessing its valuation compared to broader market moves. Recent returns suggest mixed momentum. This brings the company’s growth prospects into sharper focus for the months ahead. See our latest analysis for Sylvamo. The past year has been tough for Sylvamo shareholders, with a 1-year total shareholder return of -53.5%, reflecting both price declines and reinvested dividends. More recently, a...
NYSE:FLOC
NYSE:FLOCEnergy Services

Flowco Holdings (FLOC): Assessing Valuation After a Recent Share Price Rebound

Flowco Holdings (FLOC) shares have caught some attention lately, climbing about 16% over the past month despite a recent one-day dip. Investors seem curious about whether this momentum can continue, given mixed signals in recent performance. See our latest analysis for Flowco Holdings. The recent 30-day share price return of 16.1% for Flowco Holdings stands out against a year-to-date decline of 44.3%. This contrast suggests a spark of renewed interest even as the longer-term picture remains...
NYSE:HOG
NYSE:HOGAuto

Harley-Davidson (HOG): Evaluating Value After Q3 Earnings Beat and 2026 Model Launches

Harley-Davidson (HOG) delivered an impressive third quarter for 2025, outpacing Wall Street’s expectations. The company’s performance reflects strong execution in financial services, inventory controls, and targeted promotions. This positions Harley-Davidson for continued momentum. See our latest analysis for Harley-Davidson. Harley-Davidson has been working hard to keep momentum up, with new 2026 model launches and a sizeable share buyback rounding out a busy few months. Still, despite the...
NasdaqCM:BULL
NasdaqCM:BULLCapital Markets

Is Webull’s Recent Fintech Partnership a Sign the Market Is Missing Its Real Value?

Ever wondered if Webull is priced for a breakout, or if the market is missing something about its real value? You are definitely not alone. The stock has had a bumpy ride lately, sliding 10.9% over the past week and now down 17.0% for the year to date. This could signal shifting views about its growth outlook or risk. Many investors are still digesting Webull’s recent expansion into new financial products, as well as a high-profile partnership with a major fintech firm announced earlier this...
NasdaqGS:ASML
NasdaqGS:ASMLSemiconductor

Is Now the Right Moment for ASML After Shares Surge 45% in 2025?

Wondering if ASML Holding is a bargain or fully priced right now? You are not alone, especially with the buzz around its recent stock momentum. Despite a recent dip of 4.0% in the past week, ASML’s shares have surged 45.2% year-to-date and an impressive 53.1% over the last 12 months, sparking chatter about its growth prospects and changing risk sentiment. Much of this movement has been fueled by ongoing developments in the global semiconductor industry and ASML’s pivotal role in advancing...
NYSE:SHAK
NYSE:SHAKHospitality

Is Shake Shack’s Value Changing After Recent Store Openings and Menu Launches?

Ever found yourself wondering if Shake Shack's stock is a savvy buy or just riding the wave of hype? This is a good time to get clear on what the numbers really say about its value. After a 5.0% gain over the last month but a sharp 31.6% drop year-to-date, Shake Shack’s recent price swings have caught plenty of investor attention. Adding fuel to the movement, news around new store openings and innovative menu launches have sparked renewed optimism about the company’s growth trajectory. At...
NYSE:MTDR
NYSE:MTDROil and Gas

A Fresh Look at Matador Resources (MTDR) Valuation After Recent Share Price Rebound

Matador Resources (MTDR) has seen its stock pop just over 3% today. That move comes as energy stocks gain some traction and gives investors a fresh data point to watch after a difficult run for the company. See our latest analysis for Matador Resources. Matador Resources’ 1-day share price jump stands out against a tough backdrop, with this year’s share price return sitting at -32.25%. Despite that, the stock's five-year total shareholder return is a remarkable 409.8%. This reflects its...
NYSE:ESRT
NYSE:ESRTOffice REITs

Does ESRT’s New SORA and Rolex Leases Signal Enduring Demand for Prime Manhattan Properties?

Empire State Realty Trust recently announced its third-quarter 2025 earnings, reporting sales of US$158.41 million and new tenant leases for a 14,430 sq. ft. SORA fine dining venue at One Grand Central Place and a 3,709 sq. ft. Rolex retail store at North Sixth Street. Alongside reaffirmed earnings guidance for the year, these developments highlight ongoing tenant interest in its premium Manhattan properties during a period of shifting market conditions. We'll examine how the new...
NYSE:VNO
NYSE:VNOOffice REITs

Vornado Realty Trust (VNO): Assessing Valuation Following Q3 Profit Turnaround and Strategic Manhattan Moves

Vornado Realty Trust (VNO) just delivered a third-quarter earnings report that turned heads, reversing last year’s loss with a solid profit. This shift was fueled by strong leasing activity in Manhattan and gains from a new master lease with NYU. See our latest analysis for Vornado Realty Trust. This fresh batch of upbeat news, paired with active Manhattan leasing and high-profile property deals, has brought renewed attention to Vornado’s momentum. While the stock has experienced some bumps...
NasdaqGS:MLYS
NasdaqGS:MLYSBiotechs

Mineralys Therapeutics (MLYS): Assessing Valuation Following Positive Phase 3 Results for Lorundrostat and FDA Filing Plans

Mineralys Therapeutics (MLYS) shared key Phase 3 data for lorundrostat at ASN Kidney Week 2025. The results showed clear reductions in blood pressure and albuminuria in chronic kidney disease and hypertension patients. See our latest analysis for Mineralys Therapeutics. Mineralys Therapeutics’ strong Phase 3 results have powered remarkable momentum, with a 90-day share price return of 188.25% and a year-to-date share price surge of 210.37%. The excitement around lorundrostat and an upcoming...
NYSE:ESAB
NYSE:ESABMachinery

ESAB (NYSE:ESAB) Valuation In Focus After Upbeat Q3 Earnings and Upgraded 2025 Sales Outlook

ESAB (NYSE:ESAB) reported third quarter earnings that surpassed expectations. Management highlighted a return to organic growth, early integration progress on the EWM acquisition, and an upgraded 2025 sales outlook. See our latest analysis for ESAB. Despite turbulence in broader markets, especially after a recent tech-driven rally prompted some profit-taking, ESAB’s share price has shown resilience, with a 5.2% gain over the last 90 days and momentum building around its organic growth story...
NYSE:OWL
NYSE:OWLCapital Markets

Should You Rethink Blue Owl Capital After a 30% Drop in 2025?

Wondering if Blue Owl Capital is a bargain or overhyped? Let’s dig into what’s really going on beneath the surface and why it could matter for your portfolio. Although the stock has seen a 2.2% dip over the last week and is still down 30.6% for the year, its three-year return sits at a robust 29.0%. The stock has moved between periods of promise and uncertainty. Recently, Blue Owl Capital has been in the spotlight as industry headlines focus on the wave of private credit deals and the...